Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr;39 Suppl 1(Suppl 1):i110-21.
doi: 10.1093/ije/dyq028.

Folic acid to reduce neonatal mortality from neural tube disorders

Hannah Blencowe  1 , Simon Cousens, Bernadette Modell, Joy Lawn
Affiliations
Review

Folic acid to reduce neonatal mortality from neural tube disorders

Hannah Blencowe et al. Int J Epidemiol. 2010 Apr.

Abstract

Background: Neural tube defects (NTDs) remain an important, preventable cause of mortality and morbidity. High-income countries have reported large reductions in NTDs associated with folic acid supplementation or fortification. The burden of NTDs in low-income countries and the effectiveness of folic acid fortification/supplementation are unclear.

Objective: To review the evidence for, and estimate the effect of, folic acid fortification/supplementation on neonatal mortality due to NTDs, especially in low-income countries.

Methods: We conducted systematic reviews, abstracted data meeting inclusion criteria and evaluated evidence quality using adapted Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. Where appropriate, meta-analyses were performed.

Results: Meta-analysis of three randomized controlled trials (RCTs) of folic acid supplementation for women with a previous pregnancy with NTD indicates a 70% [95% confidence interval (CI): 35-86] reduction in recurrence (secondary prevention). For NTD primary prevention through folic acid supplementation, combining one RCT with three cohort studies which adjusted for confounding, suggested a reduction of 62% (95% CI: 49-71). A meta-analysis of eight population-based observational studies examining folic acid food fortification gave an estimated reduction in NTD incidence of 46% (95% CI: 37-54). In low-income countries an estimated 29% of neonatal deaths related to visible congenital abnormalities are attributed to NTD. Assuming that fortification reduces the incidence of NTDs, but does not alter severity or case-fatality rates, we estimate that folic acid fortification could prevent 13% of neonatal deaths currently attributed to congenital abnormalities in low-income countries.

Discussion: Scale-up of periconceptional supplementation programmes is challenging. Our final effect estimate was therefore based on folic acid fortification data. If folic acid food fortification achieved 100% population coverage the number of NTDs in low-income countries could be approximately halved.

Conclusion: The evidence supports both folic acid supplementation and fortification as effective in reducing neonatal mortality from NTDs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Synthesis of study identification in the review of the effect of folic acid on neonatal mortality form neural tube disorders. Detailed Pubmed search terms: ("folic acid"[MeSH Terms] OR ("folic"[All Fields] AND "acid"[All Fields]) OR "folic acid"[All Fields]) AND ("neural tube defects"[MeSH Terms] OR ("neural"[All Fields] AND "tube"[All Fields] AND "defects"[All Fields]) OR "neural tube defects"[All Fields] OR ("neural"[All Fields] AND "tube"[All Fields] AND "defect"[All Fields]) OR "neural tube defect"[All Fields]) AND ("infant, newborn"[MeSH Terms] OR ("infant"[All Fields] AND "newborn"[All Fields]) OR "newborn infant"[All Fields] OR "neonate"[All Fields]) OR ("infant mortality"[MeSH Terms] OR ("infant"[All Fields] AND "mortality"[All Fields]) OR "infant mortality"[All Fields] OR ("neonatal"[All Fields] AND "mortality"[All Fields]) OR "neonatal mortality"[All Fields]) OR ("women"[MeSH Terms] OR "women"[All Fields] OR "female"[MeSH Terms] OR "female"[All Fields] OR "pregnancy"[MeSH Terms] OR "pregnancy"[All Fields] OR periconceptual[All Fields] OR "peri conceptual"[All Fields]) Embase/ WHO regional databases: ‘neural tube defects’ ‘folic acid’
Figure 2
Figure 2
Meta analysis of the effect of folic acid supplementation. (a) Prevention of recurrent neural tube disorders (secondary prevention), Relative Risk (95% Confidence Interval); Heterogeneity χ2 = 0.28 (degrees of freedom (df = 2) P = 0.867, I2 (variation in RR attributable to heterogeneity) = 0%, Test of RR = 1: z = 3.06, P = 0.002. (b) Primary prevention of neural tube disorders, Relative Risk (95% Confidence Interval), Heterogeneity χ2 = 4.16 (df = 3) P = 0.244, I2 (variation in RR attributable to heterogeneity) = 27.9%, Test of RR = 1: z = 6.59, P < 0.001
Figure 3
Figure 3
Meta-analysis (random effects) of the effect of folic acid fortification on primary prevention of neural tube defects. Heterogeneity χ2 = 22.73 (df = 7), P = 0.002, I2 (variation in RR attributable to heterogeneity) = 69.2%; Estimate of between-study variance τ2 = 0.0295, Test of RR = 1: z = 8.01, P < 0.001
Figure 4
Figure 4
Sensitivity analyses of the estimate of the effect folic acid fortification using different inclusion criteria and meta-analysis methods
See this image and copyright information in PMC

References

    1. Kulkarni A, Ehrenkranz RA, Bhandari V. Effect of introduction of synchronized nasal intermittent positive-pressure ventilation in a neonatal intensive care unit on bronchopulmonary dysplasia and growth in preterm infants. Am J Perinatol. 2006;23:233–40. - PubMed
    1. Jegatheesan P, Keller RL, Hawgood S. Early variable-flow nasal continuous positive airway pressure in infants < or =1000 grams at birth. J Perinatol. 2006;26:189–96. - PubMed
    1. The Global Burden of Disease. 2004. [(13 September 2009, date last accessed)]. update. 2004. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004updat....
    1. McIntosh N, Helms PJ, Smyth RL, editors. Forfar & Arneil's Textbook of Pediatrics. 6th. Churchill Livingstone: Edinburgh; 2003. pp. 902–907.
    1. Wyszynski DF, editor. Neural Tube Defects: from Origin to Treatment. US: Oxford University Press; 2006. pp. 250–71.